Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 104

1.

Clinical efficacy of free androgen index, a surrogate hallmark of circulating free testosterone level, in male patients with HCV-related chronic liver disease.

Himoto T, Fujita K, Sakamoto T, Nomura T, Morishita A, Yoneyama H, Haba R, Masaki T.

J Clin Biochem Nutr. 2018 Nov;63(3):238-245. doi: 10.3164/jcbn.18-30. Epub 2018 Jun 8.

2.

Fibrosis Staging Using Direct Serum Biomarkers is Influenced by Hepatitis Activity Grading in Hepatitis C Virus Infection.

Fujita K, Kuroda N, Morishita A, Oura K, Tadokoro T, Nomura T, Yoneyama H, Arai T, Himoto T, Watanabe S, Masaki T.

J Clin Med. 2018 Sep 11;7(9). pii: E267. doi: 10.3390/jcm7090267.

3.

Circulating microRNA-636 is associated with the elimination of hepatitis C virus by ombitasvir/paritaprevir/ritonavir.

Morishita A, Yoneyama H, Iwama H, Fujita K, Watanabe M, Hirose K, Tadokoro T, Oura K, Sakamoto T, Mimura S, Nomura T, Oryu M, Himoto T, Shimotohno K, Masaki T.

Oncotarget. 2018 Aug 10;9(62):32054-32062. doi: 10.18632/oncotarget.25889. eCollection 2018 Aug 10.

4.

Serum miRNAs Predicting Sustained HBs Antigen Reduction 48 Weeks after Pegylated Interferon Therapy in HBe Antigen-Negative Patients.

Fujita K, Mimura S, Iwama H, Nakahara M, Oura K, Tadokoro T, Nomura T, Tani J, Yoneyama H, Morishita A, Oryu M, Himoto T, Nishitsuji H, Shimotohno K, Omata M, Masaki T.

Int J Mol Sci. 2018 Jul 2;19(7). pii: E1940. doi: 10.3390/ijms19071940.

5.

α-Catenin Controls the Anisotropy of Force Distribution at Cell-Cell Junctions during Collective Cell Migration.

Matsuzawa K, Himoto T, Mochizuki Y, Ikenouchi J.

Cell Rep. 2018 Jun 19;23(12):3447-3456. doi: 10.1016/j.celrep.2018.05.070.

6.

Targeted sequencing of cancer-associated genes in hepatocellular carcinoma using next-generation sequencing.

Morishita A, Iwama H, Fujihara S, Watanabe M, Fujita K, Tadokoro T, Ohura K, Chiyo T, Sakamoto T, Mimura S, Nomura T, Tani J, Yoneyama H, Okano K, Suzuki Y, Himoto T, Masaki T.

Oncol Lett. 2018 Jan;15(1):528-532. doi: 10.3892/ol.2017.7334. Epub 2017 Nov 2.

7.

Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease.

Himoto T, Masaki T.

Nutrients. 2018 Jan 14;10(1). pii: E88. doi: 10.3390/nu10010088. Review.

8.

Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.

Samukawa E, Fujihara S, Oura K, Iwama H, Yamana Y, Tadokoro T, Chiyo T, Kobayashi K, Morishita A, Nakahara M, Kobara H, Mori H, Okano K, Suzuki Y, Himoto T, Masaki T.

Int J Oncol. 2017 Dec;51(6):1674-1684. doi: 10.3892/ijo.2017.4177. Epub 2017 Oct 23.

9.

Induction of apoptosis by Galectin-9 in liver metastatic cancer cells: In vitro study.

Tadokoro T, Fujihara S, Chiyo T, Oura K, Samukawa E, Yamana Y, Fujita K, Mimura S, Sakamoto T, Nomura T, Tani J, Yoneyama H, Morishita A, Himoto T, Iwama H, Niki T, Hirashima M, Masaki T.

Int J Oncol. 2017 Aug;51(2):607-614. doi: 10.3892/ijo.2017.4053. Epub 2017 Jun 23.

PMID:
28656219
10.

Verification of B-lymphocyte activating factor's involvement in the exacerbation of insulin resistance as well as an autoimmune response in patients with nonalcoholic steatohepatitis and patients with HCV-related chronic liver disease.

Himoto T, Fujita K, Nomura T, Tani J, Morishita A, Yoneyama H, Haba R, Masaki T.

Diabetol Metab Syndr. 2017 Jun 13;9:45. doi: 10.1186/s13098-017-0243-z. eCollection 2017.

11.

Correlation between serum galectin-9 levels and liver fibrosis.

Fujita K, Niki T, Nomura T, Oura K, Tadokoro T, Sakamoto T, Tani J, Yoneyama H, Morishita A, Kuroda N, Arai T, Nishimoto N, Himoto T, Hirashima M, Masaki T.

J Gastroenterol Hepatol. 2018 Feb;33(2):492-499. doi: 10.1111/jgh.13851.

PMID:
28618039
12.

Galectin‑9 ameliorates fulminant liver injury.

Tadokoro T, Morishita A, Sakamoto T, Fujihara S, Fujita K, Mimura S, Oura K, Nomura T, Tani J, Yoneyama H, Iwama H, Himoto T, Niki T, Hirashima M, Masaki T.

Mol Med Rep. 2017 Jul;16(1):36-42. doi: 10.3892/mmr.2017.6606. Epub 2017 May 18.

13.

MicroRNA profile of hepatic epithelioid hemangioendothelioma: A case report.

Morishita A, Iwama H, Yoneyama H, Sakamoto T, Fujita K, Nomura T, Tani J, Miyoshi H, Fujihara S, Nishiyama N, Kobara H, Mori H, Yamamoto N, Okano K, Suzuki Y, Ibuki E, Haba R, Himoto T, Masaki T.

Oncol Lett. 2017 Mar;13(3):1655-1659. doi: 10.3892/ol.2017.5643. Epub 2017 Jan 25.

14.

Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population.

Kawashima M, Hitomi Y, Aiba Y, Nishida N, Kojima K, Kawai Y, Nakamura H, Tanaka A, Zeniya M, Hashimoto E, Ohira H, Yamamoto K, Abe M, Nakao K, Yamagiwa S, Kaneko S, Honda M, Umemura T, Ichida T, Seike M, Sakisaka S, Harada M, Yokosuka O, Ueno Y, Senju M, Kanda T, Shibata H, Himoto T, Murata K, Miyake Y, Ebinuma H, Taniai M, Joshita S, Nikami T, Ota H, Kouno H, Kouno H, Nakamuta M, Fukushima N, Kohjima M, Komatsu T, Komeda T, Ohara Y, Muro T, Yamashita T, Yoshizawa K, Nakamura Y, Shimada M, Hirashima N, Sugi K, Ario K, Takesaki E, Naganuma A, Mano H, Yamashita H, Matsushita K, Yamauchi K, Makita F, Nishimura H, Furuta K, Takahashi N, Kikuchi M, Masaki N, Tanaka T, Tamura S, Mori A, Yagi S, Shirabe K, Komori A, Migita K, Ito M, Nagaoka S, Abiru S, Yatsuhashi H, Yasunami M, Shimoda S, Harada K, Egawa H, Maehara Y, Uemoto S, Kokudo N, Takikawa H, Ishibashi H, Chayama K, Mizokami M, Nagasaki M, Tokunaga K, Nakamura M.

Hum Mol Genet. 2017 Feb 1;26(3):650-659. doi: 10.1093/hmg/ddw406.

PMID:
28062665
15.

Cancer Therapy Due to Apoptosis: Galectin-9.

Fujita K, Iwama H, Oura K, Tadokoro T, Samukawa E, Sakamoto T, Nomura T, Tani J, Yoneyama H, Morishita A, Himoto T, Hirashima M, Masaki T.

Int J Mol Sci. 2017 Jan 1;18(1). pii: E74. doi: 10.3390/ijms18010074. Review.

16.

Metformin-suppressed differentiation of human visceral preadipocytes: Involvement of microRNAs.

Fujita K, Iwama H, Oura K, Tadokoro T, Hirose K, Watanabe M, Sakamoto T, Katsura A, Mimura S, Nomura T, Tani J, Miyoshi H, Morishita A, Yoneyama H, Okano K, Suzuki Y, Himoto T, Masaki T.

Int J Mol Med. 2016 Oct;38(4):1135-40. doi: 10.3892/ijmm.2016.2729. Epub 2016 Sep 2.

17.

MicroRNA profiles in various hepatocellular carcinoma cell lines.

Morishita A, Iwama H, Fujihara S, Sakamoto T, Fujita K, Tani J, Miyoshi H, Yoneyama H, Himoto T, Masaki T.

Oncol Lett. 2016 Sep;12(3):1687-1692. Epub 2016 Jul 13.

18.

Identification of microRNA profiles associated with refractory primary biliary cirrhosis.

Sakamoto T, Morishita A, Nomura T, Tani J, Miyoshi H, Yoneyama H, Iwama H, Himoto T, Masaki T.

Mol Med Rep. 2016 Oct;14(4):3350-6. doi: 10.3892/mmr.2016.5606. Epub 2016 Aug 9.

PMID:
27511723
19.

Diagnostic Dilemma in the Detection of Antibodies to Filamentous Actin.

Himoto T, Fujita K, Nomura T, Tani J, Miyoshi H, Morishita A, Yoneyama H, Haba R, Masaki T.

Clin Lab. 2016;62(5):839-47.

PMID:
27349009
20.

Roles of Copper in Hepatocarcinogenesis via the Activation of Hypoxia-Inducible Factor-1α.

Himoto T, Fujita K, Nomura T, Tani J, Miyoshi H, Morishita A, Yoneyama H, Kubota S, Haba R, Suzuki Y, Masaki T.

Biol Trace Elem Res. 2016 Nov;174(1):58-64. Epub 2016 Apr 28.

PMID:
27121973

Supplemental Content

Loading ...
Support Center